Deepak L Bhatt

1. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
   2023/09/25 by Stephen J. Nicholls, Deepak L. Bhatt, Deepak L Bhatt +29 · 31 citations
   Medicine · #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients #Diabetes, Cardiovascular Risks, and Lipoproteins
2. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
   2020/07/29 by Matthew J. Budoff, Matthew J Budoff, Deepak L. Bhatt +17 · 3 citations
   Medicine · Nursing · #Cardiovascular Health and Disease Prevention #Fatty Acid Research and Health #Lipoproteins and Cardiovascular Health